1. Home
  2. APLT vs OPHC Comparison

APLT vs OPHC Comparison

Compare APLT & OPHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLT
  • OPHC
  • Stock Information
  • Founded
  • APLT 2016
  • OPHC 2000
  • Country
  • APLT United States
  • OPHC United States
  • Employees
  • APLT N/A
  • OPHC N/A
  • Industry
  • APLT Biotechnology: Pharmaceutical Preparations
  • OPHC Major Banks
  • Sector
  • APLT Health Care
  • OPHC Finance
  • Exchange
  • APLT Nasdaq
  • OPHC Nasdaq
  • Market Cap
  • APLT 37.5M
  • OPHC 43.1M
  • IPO Year
  • APLT 2019
  • OPHC N/A
  • Fundamental
  • Price
  • APLT $0.40
  • OPHC $4.61
  • Analyst Decision
  • APLT Buy
  • OPHC Hold
  • Analyst Count
  • APLT 7
  • OPHC 1
  • Target Price
  • APLT $6.10
  • OPHC $5.25
  • AVG Volume (30 Days)
  • APLT 1.9M
  • OPHC 15.7K
  • Earning Date
  • APLT 05-20-2025
  • OPHC 05-20-2025
  • Dividend Yield
  • APLT N/A
  • OPHC N/A
  • EPS Growth
  • APLT N/A
  • OPHC 53.23
  • EPS
  • APLT N/A
  • OPHC 1.33
  • Revenue
  • APLT $455,000.00
  • OPHC $37,091,000.00
  • Revenue This Year
  • APLT $1,768.13
  • OPHC N/A
  • Revenue Next Year
  • APLT $361.28
  • OPHC N/A
  • P/E Ratio
  • APLT N/A
  • OPHC $3.44
  • Revenue Growth
  • APLT N/A
  • OPHC 60.44
  • 52 Week Low
  • APLT $0.30
  • OPHC $3.53
  • 52 Week High
  • APLT $10.62
  • OPHC $5.90
  • Technical
  • Relative Strength Index (RSI)
  • APLT 46.92
  • OPHC 72.33
  • Support Level
  • APLT $0.39
  • OPHC $4.20
  • Resistance Level
  • APLT $0.44
  • OPHC $4.51
  • Average True Range (ATR)
  • APLT 0.04
  • OPHC 0.12
  • MACD
  • APLT 0.01
  • OPHC 0.05
  • Stochastic Oscillator
  • APLT 45.49
  • OPHC 97.73

About APLT Applied Therapeutics Inc.

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

About OPHC OptimumBank Holdings Inc.

OptimumBank Holdings Inc serves as a bank holding company for OptimumBank. The Bank provides a range of community banking services to individuals and corporate customers. Its services include demand interest-bearing and non-interest-bearing accounts, negotiable order of withdrawal account, money market deposit accounts, debit cards, and automated teller machines.

Share on Social Networks: